EMILIO
GIL MARTIN
TITULAR DE UNIVERSIDADE - TEMPO COMPLETO
Instituto de Salud Carlos III
Madrid, EspañaInstituto de Salud Carlos III -ko ikertzaileekin lankidetzan egindako argitalpenak (3)
2022
-
Coronavirus Disease 2019 (COVID-19) and Its Neuroinvasive Capacity: Is It Time for Melatonin?
Cellular and Molecular Neurobiology, Vol. 42, Núm. 3, pp. 489-500
2021
-
The coronavirus disease 2019 (Covid-19): Key emphasis on melatonin safety and therapeutic efficacy
Antioxidants, Vol. 10, Núm. 7
2019
-
Potential of melatonin as adjuvant therapy of oral cancer in the era of epigenomics
Cancers, Vol. 11, Núm. 11